Director/PDMR Shareholding
Eco Animal Health Group Plc
ECO Animal Health Group plc ("ECO" or the "Company")
Director/PDMR Shareholding and Notification
1. | Â | Details of the person discharging managerial responsibilities / person closely associated | |||
a. | Name | Â | Andrew Buglass | ||
2. | Reason for the notification | ||||
a. | Position/status | PDMR | |||
b. |
Initial notification
/Amendment |
Initial notification | |||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a. | Name | ECO Animal Health Group plc | |||
b. | LEI | 01818170 | |||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a. |
Description of the
Financial instrument, type of instrument Identification code |
Ordinary shares of 5p each in the capital of the Company (“Ordinary
Sharesâ€)
  ISIN: GB0032036807 LEI: 2138009XN9DJ3YP7OB55 |
|||
b. | Nature of the transaction |
Exercise of 25,000 options over Ordinary Shares with an exercise
price of £2.05
 Sale of 25,000 Ordinary Shares at a price of £5.10 |
|||
c. | Price(s) and volume(s) |
                     Price(s)          Volume(s)  Exercise       £2.05              25,000  Sale              £5.10             25,000  |
|||
d. |
Aggregated information
· Aggregated volume · Price |
As above |
|||
e. | Date of the transaction | 2018/07/19 | |||
f. | Place of the transaction | London Stock Exchange (XLON) AIM market |
1. | Â | Details of the person discharging managerial responsibilities / person closely associated | |||
a. | Name | Â | Elizabeth Abbott | ||
2. | Reason for the notification | ||||
a. | Position/status | PDMR | |||
b. |
Initial notification
/Amendment |
Initial notification | |||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a. | Name | ECO Animal Health Group plc | |||
b. | LEI | 01818170 | |||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a. |
Description of the
Financial instrument, type of instrument Identification code |
Ordinary shares of 5p each in the capital of the Company (“Ordinary
Sharesâ€)
  ISIN: GB0032036807 LEI: 2138009XN9DJ3YP7OB55 |
|||
b. | Nature of the transaction |
Exercise of 15,850 options over Ordinary Shares with an exercise
price of £1.96
Exercise of 1,100 options over Ordinary Shares with an exercise price of £1.615  Sale of 16,950 Ordinary Shares at a price of £5.10 |
|||
c. | Price(s) and volume(s) |
                       Price(s)          Volume(s)  Exercise           £1.96             15,850                         £1.615            1,100  Sale                 £5.10              16,950  |
|||
d. |
Aggregated information
· Aggregated volume · Price |
As above |
|||
e. | Date of the transaction | 2018/07/19 | |||
f. | Place of the transaction | London Stock Exchange (XLON) AIM market |
Enquiries
ECO Animal Health Group plc
Marc Loomes, CEO 020 8447 8899
Peter Lawrence, Non -Executive Chairman 020 8336 6190
Spiro Financial
Anthony Spiro 020 8336 6196
N+1 Singer (Nominated Adviser)
Mark Taylor, James White, Brough Ransom 020 7496 3000
Peel Hunt LLP (Joint Broker)
James Steel, Dr Christopher Golden 020 7418 8900
View source version on businesswire.com: https://www.businesswire.com/news/home/20180720005239/en/